{
  "denotations": [
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 43,
        "end": 58
      }
    },
    {
      "id": "T3",
      "obj": "Chemical",
      "span": {
        "begin": 186,
        "end": 210
      }
    },
    {
      "id": "T4",
      "obj": "Chemical",
      "span": {
        "begin": 215,
        "end": 224
      }
    },
    {
      "id": "T5",
      "obj": "Chemical",
      "span": {
        "begin": 177,
        "end": 224
      }
    },
    {
      "id": "T6",
      "obj": "Disease",
      "span": {
        "begin": 135,
        "end": 143
      }
    },
    {
      "id": "T9",
      "obj": "Disease",
      "span": {
        "begin": 161,
        "end": 166
      }
    },
    {
      "id": "T10",
      "obj": "Chemical",
      "span": {
        "begin": 287,
        "end": 310
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "27522730_20",
  "text": "Combination of blood group specificity and interleukin 28B gene polymorphism is a simple and reliable predictor of SVR and dynamics of fibrosis in patients with CHC-I receiving AVT with pegylated interferon a-2 and ribavirin ; also , it may be an instrument of selection of patients for interferon-free therapy ."
}
